BioFire Defense

In critical care environments, treating lower respiratory infections based on non-specific clinical symptoms alone can lead to broad-spectrum antibiotic overuse and unnecessary diagnostic delays.
The BIOFIRE® FILMARRAY® Pneumonia Panel running on the high-throughput BIOFIRE® TORCH System delivers comprehensive identification for viral and bacterial pathogens in about an hour.

Giving clinical teams actionable, quantitative results directly from central laboratories optimize antimicrobial stewardship and support targeted care when every moment counts.

As Respiratory Care Week concludes, BioFire Defense thanks the respiratory therapists and laboratory professionals safeguarding patient health every day.

Discover how high-yield syndromic testing strengthens critical care, contact us today to learn more: https://biofiredefense.com/contact-us/

Utah is quickly becoming one of the most exciting hubs in the country for biotech and healthcare innovation.

In a recent piece by Deseret News, BioFire Defense CEO John Harris weighed in on the growing local life sciences scene and what it takes to protect public health on a global scale. During a panel with leaders from BioHive and the University of Utah, John talked about how our local team develops diagnostic tools that help defend military personnel and communities when health threats emerge. We are proud to be part of Utah's thriving biotech community and to help drive the innovations keeping people safe.

Check out the full Deseret News story here: https://www.deseret.com/business/2026/10/13/utah-life-sciences-health-innovation-biotech-economic-impacts-university-of-utah-biodefense/

The Utah economic juggernaut that most people are missing State has more than 1,600 life science and biotech companies and is growing rapidly.

BioFire Defense and bioMérieux are proud to share that Marianne Kim, PhD, VP of Research & Development at BioFire Defense, and Andy Hemmert, PhD, SVP of Molecular Research & Development at bioMérieux, have been recognized as 2026 Healthcare Heroes by Utah Business.

This prestigious recognition highlights their extraordinary leadership and technical vision in advancing molecular diagnostic innovation across Utah's growing life sciences sector. Through their dedication to engineering rapid PCR testing solutions, Dr. Kim and Dr. Hemmert continue to strengthen diagnostic readiness and empower frontline medical teams protecting public health worldwide. Join us in celebrating their achievement and ongoing commitment to clinical excellence.
Read the full Utah Business announcement to learn more about this year's honorees: https://www.utahbusiness.com/awards-and-rankings/2026/10/02/introducing-the-2026-healthcare-heroes/

When respiratory surges hit frontline clinics and urgent care centers, rapid triage is critical to keeping care workflows moving. The BIOFIRE® SPOTFIRE® System brings PCR testing directly to the point of care, detecting up to 15 respiratory pathogens in about 15 minutes from a single swab. Delivering fast, actionable clarity empowers respiratory therapists and clinical providers to make confident treatment decisions, avoid unnecessary antibiotic prescriptions, and reduce the downtime of our troops.

Explore how the BIOFIRE® SPOTFIRE® System transforms point-of-care care through the link in our bio.

In modern tactical environments, fast biothreat identification is critical to force survival and operational success.

Join Matt Scullion, Vice President of Business Development at BioFire Defense, on November 5 at 2:45 PM ET at CBRNe Convergence in Knoxville for his presentation, "Into the Wilderness – Bio Identification and Diagnostics in the Era of Drone Warfare."

His session will address the development challenges of the new battlespace, overcoming the challenges of time and distance, and adapting frontline triage when the traditional Golden Hour no longer exists.

Interested in learning more before CBRNe, contact us: https://biofiredefense.com/contact-us/

BioFire Defense is heading to Convergence 2026 in Knoxville, Tennessee, November 3–5. Stop by Booth 212 to meet our team and explore how our PCR systems support defense health readiness across complex operational environments.

Learn more about our biodefense diagnostic solutions: https://biofiredefense.com/

First proclaimed by President Ronald Reagan in 1982 following his recovery from an assassination attempt aided by dedicated care teams, Respiratory Care Week honors the vital contributions of respiratory therapists nationwide.

This year’s theme, "Every Breath, Every Moment," highlights the dedication of respiratory therapists and pulmonary specialists who safeguard patient health during seasonal surges and critical care emergencies. BioFire Defense proudly salutes the respiratory therapists, clinical laboratory professionals, and military medical personnel who deliver uncompromised care on the front lines every day.

Learn how our diagnostic solutions support critical care teams: https://biofiredefense.com/clinical-ivd/

Respiratory season surges create immediate bottlenecks in military clinics and urgent care centers. The BIOFIRE® SPOTFIRE® System provides fast, multiplex PCR diagnostic results right at the point of care, detecting up to 15 respiratory targets in about 15 minutes.

Delivering fast diagnostic clarity from a single swab helps healthcare providers optimize triage, avoid unnecessary broad-spectrum antibiotic usage, and return service members to active duty without delay.

Multi-vendor diagnostic procurement introduces administrative friction, logistics delays, and supply chain risk when clinical demand spikes. Standardizing with BioFire Defense simplifies ordering while protecting force health across all defense health networks.

As the sole supplier of the BIOFIRE® portfolio to the U.S. Department of War and federal agencies, BioFire Defense delivers unbroken supply security, direct technical support, and fast testing capabilities to military treatment facilities nationwide. Streamline your facility's diagnostic supply chain before peak surge season arrives.

Contact us to learn more about sole-source procurement integration: https://biofiredefense.com/contact-us/

When patients who have had contact with high-consequence pathogens present with fever, medical teams need fast differential diagnosis to guide immediate containment. Building on a shared legacy supporting global Ebola response efforts with bioMérieux, BioFire Defense is expanding diagnostic capabilities with Emergency Use Authorization for the BIOFIRE® Global Fever Special Pathogens (GF SP) Panel.

The BIOFIRE GF SP Panel delivers fast, accurate multiplex PCR results from a single blood sample — targeting Ebola Virus and several other viral, bacterial, and parasitic biothreats simultaneously to eliminate diagnostic guesswork.

Read the official press release to learn more:

www.biomerieux.com